Preclinical pharmacokinetic characterization of 2-(4-(4-(5-(2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamido)-1H-benzo[d]imidazol-2-yl)phenyl)cyclohexyl) acetic acid, a novel DGAT-1 inhibitor.
about
Preclinical pharmacokinetic characterization of 2-(4-(4-(5-(2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamido)-1H-benzo[d]imidazol-2-yl)phenyl)cyclohexyl) acetic acid, a novel DGAT-1 inhibitor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@en
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@nl
type
label
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@en
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@nl
prefLabel
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@en
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@nl
P2093
P2860
P1433
P1476
Preclinical pharmacokinetic ch ...... cid, a novel DGAT-1 inhibitor.
@en
P2093
Eun-Young Kwak
Hyewon Seo
Hyun Jung Kwak
Jaechun Woo
Jin Hee Ahn
Jin Sook Song
Myung Ae Bae
Sung-Hoon Ahn
Sunjoo Ahn
P2860
P304
P356
10.3109/00498254.2013.847218
P407
P577
2013-10-23T00:00:00Z